Antiviral atomized liquid and preparation process thereof
By developing an antiviral atomizing liquid containing cordyceps, the active ingredients are extracted using enzymatic lysis and supercritical extraction technology, combined with diluents and seasoning treatment, micron-scale particles are formed, which solves the lungs caused by air pollution and the infection of the new coronavirus. Threat, achieving efficient antibacterial and antiviral effects, suitable for a variety of lung protection needs.
Patent Information
- Application Number
- CN202410953441.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Air pollution and coronavirus infection pose a serious threat to the lungs, and existing preventive measures are insufficient, especially in the case of insufficient vaccine supply and vaccination restrictions, there is a lack of effective antiviral measures.
Develop an antiviral atomizing liquid, made from raw materials such as water, Cordyceps powder, honeysuckle, edible essence, edible glycerin, natural menthol and ginger powder, and extract Cordyceps using enzymatic and supercritical extraction, combined with diluents , seasoning and purification treatment to form micron-scale particles directly to the alveoli, with antibacterial and antiviral effects.
This atomized liquid can effectively inhibit Klebsiella pneumoniae, Pseudomonas aeruginosa, Candida albicans, Staphylococcus aureus and E. coli. It has an antibacterial rate of more than 99.9%, and is resistant to coronaviruses, safe and non-toxic. Suitable for smokers and those who need lung protection.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The present invention relates to the field of novel coronavirus prevention technology, and specifically to an antiviral atomized liquid and a preparation process thereof. Background Art
[0002] The lung is the respiratory organ of the human body and an important hematopoietic organ of the human body. It is located in the chest cavity, one on each side, covering the heart. The lung has five lobes, two on the left and three on the right. The lung meridian and lung system (referring to the trachea, bronchi, etc.) are connected to the throat and nose, so the throat is called the gateway to the lungs, and the nose is the external orifice of the lungs.
[0003] The lung is a delicate organ, which summarizes the physiological and pathological characteristics of the lung. Physiologically, the lung is pure and delicate, full when inhaling and empty when exhaling. It is the canopy of the internal organs and the meeting point of all meridians. Pathologically, external infection enters the lungs through the skin or mouth and nose, and it is easy to cause disease in the lungs. Pathological changes in other internal organs also often affect the lungs.
[0004] The harm of smoking and lung infection: A large number of epidemiological studies around the world have confirmed that smoking is the primary risk factor for lung cancer. Experts point out that 70% to 80% of lung cancer is related to smoking (including passive smoking), and other related factors are: radiation exposure factors, environmental or occupational exposure (such as dust operations) factors, genetic or familial factors, etc. It is understood that the smoking rate of men in my country remains at about 66%, and has declined in recent years, but the smoking rate of women is slowly increasing.
[0005] Smoking can indeed harm the lungs. There are many neatly arranged "brushes" in the 23rd to 25th level bronchial tubes of the lungs. These "brushes" perform "purification" work layer by layer, allowing harmful substances in the inhaled air to be discharged from the lungs, thus purifying the alveoli. Experiments have shown that smoking can stop these brushes from working! If the brushes stop working for a period of time every day, the lungs will definitely be damaged in a short period of time. If not protected, it may cause breathing difficulties, changes in body temperature, coughing, increased sputum volume and sputum characteristics, and even develop into lung cancer.
[0006] Air pollutants cause many kinds of harm to the human body, the main manifestations being respiratory diseases and physiological dysfunction, as well as irritation of mucous membranes such as the eyes and nose. It is also a chronic factor causing asthma in the elderly, and insufficient lung qi can also lead to a decline in physical strength.
[0007] The impacts of air pollution on health can be divided into acute and chronic hazards: acute hazards are mainly caused by a sharp increase in the concentration of atmospheric pollutants in a short period of time (such as severe haze), which mainly manifests as acute attacks of respiratory and eye irritation symptoms, coughing, chest pain, difficulty breathing, sore throat, headache, vomiting and other diseases.
[0008] Chronic hazards mainly include: chronic inflammation of the eyes and respiratory system caused by long-term irritation, such as conjunctivitis, pharyngitis, tracheitis, etc., severe cases causing chronic obstructive pulmonary disease, and then leading to cor pulmonale.
[0009] The body's immune function declines. In areas with severe air pollution, residents' salivary lysozyme and secretory IgA levels have declined significantly, and other immune indicators have also declined. Chronic cardiovascular and cerebrovascular diseases are aggravated. Certain pollutants in the atmosphere have sensitizing effects, aggravating allergic reactions or allergic diseases (such as asthma, allergic rhinitis, etc.). The risk of lung cancer is increased. Internationally published review articles believe that although the risk of cancer from air pollution is generally low, for lung cancer, there is a higher risk because atmospheric pollutants, especially particulate matter, often contain carcinogens such as benzo(a)pyrene (BaP) and arsenic.
[0010] The new coronavirus belongs to the coronavirus family. It spreads quickly and infects a wide range of people, posing a huge challenge to global public health security. Although a variety of vaccines have been approved and started to be administered, problems such as insufficient vaccine supply and vaccination restrictions still exist. Therefore, the development of a nebulizer to prevent new coronavirus infection has important clinical application prospects. Summary of the invention
[0011] In view of the problems pointed out in the background technology, the present invention proposes an antiviral atomized liquid and a preparation process thereof to solve the above technical problems.
[0012] The technical solution of the present invention is achieved in this way:
[0013] An antiviral atomized liquid and a preparation process thereof are prepared from the following raw materials: water, cordyceps powder, honeysuckle, edible flavor, edible glycerin, natural menthol, ginger powder and licorice powder.
[0014] The present invention is further configured that the raw materials are calculated by weight percentage: 90-93% of water, 1-3% of cordyceps militaris, 0.3-1.5% of honeysuckle, 0.3-1.5% of edible flavor, 0.3-1.5% of edible glycerin, 0.3-1.5% of natural menthol, 0.3-1.5% of ginger powder, and 0.3-1.5% of liquorice powder.
[0015] The present invention is further configured that the raw materials are calculated by weight percentage: 91% of water, 3% of cordyceps militaris, 1% of honeysuckle, 1% of edible flavor, 1% of edible glycerin, 1% of natural menthol, 1% of ginger powder, and 1% of licorice powder.
[0016] An antiviral atomized liquid and its preparation process, comprising the following steps:
[0017] Step 1, select raw materials, select the raw materials in the above weight percentage;
[0018] Step 2, extracting cordycepin, enzymolyzing Cordyceps militaris to obtain a crude extract, uniformly mixing the crude extract with 80-90% by volume of an ethanol aqueous solution as an entrainer, wherein the mass ratio of the crude extract to the entrainer is 1:10; after balancing for 10-30 minutes, performing dynamic extraction to obtain a cordycepin mixture;
[0019] Step 3, adding a diluent, adding edible glycerin to the cordycepin mixture;
[0020] Step 4, seasoning and sweetening, adding honeysuckle liquid, edible flavor, natural menthol, ginger powder and licorice powder to the cordycepin mixture;
[0021] Step 5: Filtration and purification: filtering the atomized liquid to remove impurities and sediments;
[0022] Step 6: Aging: The atomized liquid is aged for a period of time to allow the flavors to blend and mature;
[0023] Step 7: Testing: performing HPLC analysis, GC-MS testing and toxicity screening on the atomized liquid;
[0024] Step 8: Packaging and storage.
[0025] By adopting the above technical solution, the beneficial effects of the present invention are as follows:
[0026] The efficacy of the atomized liquid of the present application: 1: The atomized liquid can be atomized into micron-sized small particles that directly reach the alveoli, and is the first choice for nourishing and protecting the lungs. 2: The atomized liquid inhibits Klebsiella pneumoniae, Pseudomonas aeruginosa, Candida albicans, Staphylococcus aureus, and Escherichia coli, with an inhibition rate of more than 99.9%. 3: The atomized liquid resists coronavirus.
[0027] Overview of the aerosol liquid product of this application: 1: This product is a functional herbal aerosol liquid that can be used as medicine and food for inhalation. 2: This product belongs to special diet and complies with the national standard GB24154. 3: This product is food grade and is safe and non-toxic for inhalation. 4: It can be atomized into micron-sized small particles and reach the alveoli directly. It is the first choice for smokers to nourish and protect the lungs. 5: This product inhibits Klebsiella pneumoniae, Pseudomonas aeruginosa, Candida albicans, Staphylococcus aureus, and Escherichia coli, with an inhibition rate of more than 99%. 6: This product is anti-coronavirus. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.
[0029] Figure 1 This is a diagram showing the antibacterial effect of the atomized liquid of this application on active phenolic small molecules. DETAILED DESCRIPTION
[0030] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0031] The present invention is described as follows:
[0032] An antiviral atomized liquid and a preparation process thereof are prepared from the following raw materials: water, cordyceps powder, honeysuckle, edible flavor, edible glycerin, natural menthol, ginger powder and licorice powder.
[0033] The raw materials are calculated by weight percentage: 91% water, 3% cordyceps militaris, 1% honeysuckle, 1% edible flavor, 1% edible glycerin, 1% natural menthol, 1% ginger powder, and 1% licorice powder.
[0034] The components of the atomized liquid sample of the present application were analyzed. The main components were cordycepin, 6-gingerol, 8-gingerol, 10-gingerol, chlorogenic acid, isochlorogenic acid A, isochlorogenic acid C, caffeic acid, luteolin, glycyrrhizic acid and liquiritin in Cordyceps militaris, licorice, honeysuckle and ginger, and the contents were 45.003 μg / mL, 33.819 μg / mL, 0.008 μg / mL, 5.308 μg / mL, 0.342 μg / mL, 0.645 μg / mL, 4.027 μg / mL, 0.470 μg / mL, 0.540 μg / mL, 4.024 μg / mL and 19.628 μg / mL, respectively.
[0035] An antiviral atomized liquid and its preparation process, comprising the following steps:
[0036] Step 1, select raw materials (raw materials are water, Cordyceps militaris powder, honeysuckle, edible flavor, edible glycerin, natural menthol, ginger powder, licorice powder), select the above weight percentage of raw materials (each raw material is measured by weight percentage: water 91%, Cordyceps militaris 3%, honeysuckle 1%, edible flavor 1%, edible glycerin 1%, natural menthol 1%, ginger powder 1%, licorice powder 1%). The following raw materials are selected: water, Cordyceps militaris powder, honeysuckle, edible flavor, edible glycerin, natural menthol, ginger powder, licorice powder. Each raw material is selected according to a specific weight percentage, among which water occupies the largest proportion, reaching 91%, providing a basic solvent environment for the entire system. Cordyceps militaris powder accounts for 3%, and honeysuckle accounts for 1%, which bring certain medicinal and health values to the product. Edible flavor accounts for 1%, which is used to give the product a pleasant aroma. Edible glycerin accounts for 1%, which helps to increase the moisture retention and taste of the product. Natural menthol accounts for 1%, which can bring a cool feeling. Ginger powder accounts for 1%, which may add some unique flavor and possible health benefits to the product. Licorice powder also accounts for 1%, playing a role in blending the taste and providing some medicinal effects.
[0037] Step 2: In the process of extracting cordycepin, firstly enzymolysis is performed on Cordyceps militaris to obtain a crude extract. Subsequently, the crude extract is uniformly mixed with an ethanol aqueous solution with a volume fraction of 80-90% as an entrainer at a mass ratio of 1:10. After an equilibrium time of 10-30 minutes, a dynamic extraction operation is carried out to finally obtain a cordycepin mixture. The extraction method adopted by this product is to combine enzymolysis with supercritical extraction to obtain cordycepin in Cordyceps militaris. It is worth noting that since an ethanol aqueous solution with a volume fraction of 85% is selected as an entrainer, most of the cordyceps polysaccharides and other substances will be retained in the crude extract and cannot be extracted. This result enables cordycepin to be effectively separated from cordyceps polysaccharides. Since cordycepin is a small molecule functional substance with unique properties and efficacy, it can be used in respiratory nebulizer drugs, providing new possibilities and approaches for the treatment and prevention of related diseases.
[0038] Step 3, after obtaining the cordycepin mixture, in order to achieve a specific concentration or performance requirement, a diluent needs to be added thereto. In this process, edible glycerin was selected as a diluent to be added to the cordycepin mixture. The addition of edible glycerin needs to follow certain operating specifications and proportions. When adding, make sure to pour the edible glycerin into the cordycepin mixture evenly and slowly, and stir moderately at the same time to promote full mixing of the two and avoid excessive or uneven local concentrations. Adding edible glycerin can not only adjust the concentration of the cordycepin mixture, but may also have a certain effect on its physical properties, stability and use effects. For example, edible glycerin may help to improve the moisture retention of the mixture, improve its fluidity, or enhance its compatibility in specific applications.
[0039] Step 4: In order to enhance the taste and attractiveness of the cordycepin mixture without compromising the purity of the atomized liquid, honeysuckle liquid, edible flavors, natural menthol, ginger powder and licorice powder were added thereto. First, the honeysuckle liquid was slowly poured into the cordycepin mixture. The unique fragrance of honeysuckle added a natural and fresh flavor to the atomized liquid. Then, an appropriate amount of edible flavors was added to accurately blend a pleasant specific fragrance to further enhance the attractiveness of the atomized liquid. The addition of natural menthol brings a cool taste and a unique scent, giving users a different experience. The integration of ginger powder injects a hint of spicy and warm characteristics into the atomized liquid, enriching the overall taste level. Finally, the addition of licorice powder not only blends various flavors, but also brings a hint of sweetness to the atomized liquid. During the entire addition process, the amount and order of each ingredient are strictly controlled to ensure that they are fully integrated and will not have any adverse effects on the purity of the atomized liquid. Through such careful seasoning and sweetening treatment, the cordycepin aerosol liquid has a better taste and appeal while maintaining its purity, thereby improving its comfort and acceptance.
[0040] Step 5. After completing the flavoring and sweetening steps, in order to ensure the purity and quality of the atomized liquid, it needs to be strictly filtered and purified. First, select a filter medium with a suitable pore size, such as a microporous filter membrane or a filter. The atomized liquid passes through a filter device, and under the action of pressure or gravity, the liquid slowly passes through the filter medium. During the filtration process, larger impurity particles, sediments, and possible microorganisms are effectively blocked on the surface of the filter membrane or inside the filter. These impurities include but are not limited to incompletely dissolved solid particles, tiny foreign matter introduced during the production process, etc. The filtered atomized liquid becomes clearer and more transparent, and the purity is significantly improved. This not only helps to improve the use effect and safety of the atomized liquid, but also extends the service life of the atomization equipment and reduces the occurrence of blockages and failures.
[0041] Step 6. After filtering and purifying, the atomized liquid enters the aging stage. The atomized liquid is placed in a specific environment and aged for a period of time. This period can be several days or even weeks, depending on the characteristics of the atomized liquid and the expected effect. During the aging process, the various ingredients have sufficient time to interact and blend. The flavors of honeysuckle liquid, edible flavors, natural menthol, ginger powder and licorice powder gradually mix evenly to achieve a harmonious and balanced state. The flavors that may have been more abrupt or independent gradually become mellow and round, and the taste is more mature and rich. The aging environment usually needs to maintain a certain temperature, humidity and ventilation conditions to promote the best aging effect. At the same time, the aging atomized liquid is regularly monitored and evaluated to ensure that its quality and taste are developing in the expected direction. Through aging, the quality of the atomized liquid is further improved, bringing users a better and unique experience.
[0042] Step 7. After aging, a series of rigorous tests are required to ensure the quality, safety and effectiveness of the atomized liquid. The first is high-performance liquid chromatography (HPLC) analysis. HPLC technology can accurately determine the content and purity of various components in the atomized liquid. For example, the concentration of cordycepin can be accurately measured to ensure that it meets the expected standards. At the same time, it can also detect whether there are other possible impurities or unexpected compounds. Then a gas chromatography-mass spectrometry (GC-MS) test is performed. This test can separate and identify volatile components in the atomized liquid. It can help determine the composition and proportion of volatile components such as edible flavors, and detect whether there are any harmful volatile organic compounds. In addition, toxicity screening is required. This usually includes cytotoxicity testing, animal experiments or other related toxicity assessment methods. The purpose is to determine whether the atomized liquid has potential toxic hazards to humans or the environment under the expected conditions of use. During the test process, strictly follow the relevant experimental standards and operating specifications, use precise instruments and equipment and verified methods. The test results are recorded and analyzed in detail. If any non-compliance with the standards or potential risks are found, the formula or production process of the atomizing liquid needs to be adjusted and improved until it passes all test requirements.
[0043] Step 8. The atomizer liquid that has completed all tests and passed the test will then enter the packaging and storage stage. In terms of packaging, high-quality, pollution-free and well-sealed containers are selected. These containers are strictly sterilized to prevent the intrusion of any external impurities and ensure the purity of the atomizer liquid. The design of the packaging should not only take into account the function of protecting the product, but also be easy to use and store. The storage link is crucial. In order to maintain the freshness and effectiveness of the atomizer liquid, it needs to be placed in a cool environment. This means choosing a storage space with moderate temperature, avoid direct sunlight and good ventilation. Cool conditions help slow down the chemical reactions that may occur in various ingredients and reduce the decomposition rate of active ingredients, thereby extending the shelf life of the atomizer liquid and maintaining its optimal performance. Specifically, the ideal storage temperature is usually between 15-25 degrees Celsius. At the same time, care should be taken to avoid excessive fluctuations in the humidity of the storage environment to prevent affecting the stability of the atomizer liquid. Regularly check the stored atomizer liquid to observe whether there are any abnormal changes in its appearance, odor and performance. If any signs of deterioration are found, appropriate measures should be taken in a timely manner, such as adjusting the storage conditions or treating the product. Through careful packaging and appropriate storage, we ensure that the atomizer liquid always maintains good quality and effect before use.
[0044] The acute inhalation non-toxicity test results of the atomized liquid in this application are reported by Hunan Shanshui Testing Co., Ltd. Report number: XD2101238. Sample receipt date: June 1, 2021. Date of completion of the test: June 21, 2021. Test conclusion: The acute inhalation LC502h value of the sample stock solution for male and female mice is >10000mg / m3. According to the acute inhalation classification standard in the "Technical Specifications for Disinfection" (2002 edition), it is actually non-toxic and meets the safety requirements of 2.3.13.1 of the "Technical Specifications for Disinfection" (2002 edition). The dynamic poisoning method was used to evaluate the inhalation toxicity of the herbal liquid, and the test results showed that the product was actually non-toxic.
[0045] It has inhibitory effects on pathogenic bacteria such as Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterococcus faecalis, Staphylococcus aureus, Candida albicans, Escherichia coli, and Salmonella typhimurium.
[0046] Antibacterial effect 1: Inhibition of Klebsiella pneumoniae detection results.
[0047]
[0048] The product was commissioned to a third-party testing agency for testing, and the test was conducted according to the testing method specified in GB 15979. It was ultimately determined that the product has a strong antibacterial effect on Klebsiella pneumoniae, with an inhibition rate of >99%.
[0049] Klebsiella pneumoniae (commonly known as pneumonia bacillus) causes more than 95% of Klebsiella infections. It exists in the upper respiratory tract and intestines of the human body. When it grows and reproduces in the alveoli, it causes tissue necrosis, liquefaction, and the formation of single or multiple abscesses.
[0050] Antibacterial effect 2: Inhibition of Pseudomonas aeruginosa detection results.
[0051]
[0052] The product was commissioned to a third-party testing agency for testing, and the testing was carried out according to the testing method specified in GB 15979. It was ultimately determined that the product had a strong antibacterial effect on Pseudomonas aeruginosa, and the antibacterial rate was ≥ 99% at different time intervals.
[0053] Pseudomonas aeruginosa, formerly known as Pseudomonas aeruginosa, is an important conditional pathogen of hospital-acquired infections, with the characteristics of easy colonization, easy mutation and multi-drug resistance. Many infections caused by Pseudomonas aeruginosa occur in hospitalized patients who are weak or immunocompromised, and it is a common cause of ventilator-associated pneumonia.
[0054] Antibacterial effect 3: Inhibition of Candida albicans detection results.
[0055]
[0056] The product was commissioned to a third-party testing agency for testing, and the testing was carried out according to the testing method specified in GB 15979. It was ultimately determined that the product had a strong antibacterial effect on Candida albicans, and the antibacterial rate was ≥ 99% at different time exposure times.
[0057] Candida albicans is a fungus that usually exists in the oral cavity, upper respiratory tract, intestines and vagina of normal people. Generally, it is present in small numbers in normal bodies and does not cause disease. When the body's immune function or general defense power decreases or the mutual restraint of normal flora is out of balance, the fungus will multiply in large numbers and change its growth form (blastohyphae phase) to invade cells and cause disease.
[0058] Antibacterial effect 4: Inhibition of Staphylococcus aureus detection results.
[0059]
[0060] The product was commissioned to a third-party testing agency for testing, and the test was carried out according to the testing method specified in GB 15979. It was finally determined that the product has a strong antibacterial effect on Staphylococcus aureus. The antibacterial rate was ≥ 99% under different time exposure.
[0061] Staphylococcus aureus, also known as "golden Staphylococcus", belongs to the genus Staphylococcus, is a representative of Gram-positive bacteria, and is a common food-borne pathogenic microorganism. It often parasitizes on the skin, nasal cavity, throat, stomach, carbuncle, suppurative sores of humans and animals, and is also ubiquitous in the air, sewage and other environments.
[0062] Antibacterial effect 5: Inhibition of Escherichia coli detection results.
[0063]
[0064] The product was commissioned to a third-party testing agency for testing, and the testing was carried out according to the testing method specified in GB 15979. It was ultimately determined that the product had a strong antibacterial effect on Escherichia coli, and the antibacterial rate was ≥ 99% at different time intervals.
[0065] Escherichia coli, also known as Escherichia coli, was discovered by Escherich in 1885. Escherichia coli is a conditional pathogen that can cause gastrointestinal infections or urinary tract infections in humans and various animals under certain conditions.
[0066] Introduction to the core technology of this application:
[0067] 1: Separation technology of small molecules with anti-coronavirus activity.
[0068] Small molecules with anti-coronavirus activity.
[0069] ① Inhibit the reproduction of RNA viruses by inhibiting the synthesis of viral RNA polyadenylic acid tails.
[0070] ② It can interact with RNA polymerase, terminate the synthesis of polyadenylic acid RNA chains, and inhibit the virus.
[0071] ③Interfere with virus release and inhibit the pathological damage caused by the virus to lung tissue.
[0072] 2: Nebulization technology of active flavonoid small molecules inhibiting pulmonary fibrosis.
[0073] Active flavonoid small molecules.
[0074] ① Remove free radicals, protect lung cells and tissues from oxidative damage, and reduce the risk of pulmonary fibrosis caused by oxidative damage.
[0075] ② Reduce the infiltration of inflammatory cells and transform the immune inflammatory state into the immune anti-inflammatory repair state to play an anti-fibrosis and organ repair function.
[0076] ③ Improve airway ventilation, reduce fibroblast deposition, and prevent pulmonary fibrosis.
[0077] 3: Active single-patch small molecule substance expectorant atomization technology.
[0078] Active small molecule substances.
[0079] ① Promote the secretion of respiratory mucus and protect the inflamed throat and tracheal mucosa;
[0080] ② Dilute the thick mucus and achieve the effect of expectoration;
[0081] ③Reduce the foamy sputum in the respiratory tract and enlarge the effective ventilation cavity to achieve the effect of airway patency.
[0082] 4: Anti-inflammatory atomization technology of active phenolic small molecules.
[0083] Active phenolic small molecules.
[0084] ① Prevent chronic inflammation of the respiratory tract, including chronic obstructive pulmonary disease, asthma, etc., by inhibiting the activation of macrophages and neutrophils;
[0085] ② Regulate the secretion of cellular inflammatory factors through negative regulation of monocytes and leukocytes.
[0086] 5: Use atomization technology to efficiently deliver active substances to the entire respiratory system.
[0087] Ingredients of atomizing liquid: water, Cordyceps militaris powder, honeysuckle, edible flavor, edible glycerin, natural menthol, ginger powder, licorice powder.
[0088] Core ingredient: Cordyceps militaris cordycepin.
[0089] Atomizing liquid research and development ideas and effect principles:
[0090] 1. Cordycepin is a specific activator of adenosine receptors.
[0091] Adenosine is a metabolite of ATP in the energy metabolism pathway. Scientists call it the "substance of life". Adenosine is an important information substance that the body lacks after energy consumption. It can activate a series of immune repair and recovery mechanisms of the human body, such as sleep, immune system, tissue repair, energy regeneration, removal of bacteria, viruses, cancer cells, and waste. The adenosine receptor family (proteins that can specifically bind to adenosine) includes four members, namely adenosine receptors A1, A2A, A2B, and A3. At present, it has been reported that cordycepin and adenosine receptor subtypes such as A1, A2A, A2B, and A3 can interact to produce anti-inflammatory, cell repair, and protection of the lungs, liver, kidneys, cardiovascular, and brain. Adenosine has a high affinity for adenosine receptor subtypes A1 and A2A, but has a lower affinity for adenosine receptor subtypes A2B and A3. Cordycepin has a good affinity for A1, A2A, and A2B, which is a relatively superior aspect of cordycepin.
[0092] 2. Cordycepin is a strong antioxidant.
[0093] Free radicals are intermediate products of various biochemical reactions in life activities. However, if there are too many free radicals in the body or they are removed too slowly, they will attack and damage large biological molecules, such as cell membranes, mitochondrial functions, nucleic acids, and body proteins. In the process of viral pneumonia, superoxide free radicals can damage mitochondrial functions and cause mitochondrial dysfunction, which is one of the important factors leading to lung cell dysfunction during acute respiratory failure. Cordycepin, i.e. 3′-deoxyadenosine, is easily oxidized and reduced to adenosine, and this process can reduce free radicals in tissues. Studies have shown that low concentrations of cordycepin can effectively inhibit the oxidation reaction of free radicals, remove free radicals, protect mitochondrial functions, and protect cells and tissues throughout the body from oxidative damage.
[0094] 3. Cordycepin can selectively inhibit messenger RNA polynucleotides.
[0095] The formation of chains is anti-viral and anti-tumor.
[0096] 4. Cordycepin inhibits the reproduction of RNA viruses by inhibiting the synthesis of RNA polyadenylic acid tails. Cordycepin is an important active ingredient in the new resource food Cordyceps militaris. Scientific research has confirmed that cordycepin can effectively inhibit the replication and reproduction of a variety of RNA and DNA viruses. Literature reports that cordycepin can inhibit the reproduction of the following RNA viruses: influenza virus (Influenzavirus), poliovirus. (Poliovirus), rhinovirus (Rhinovirus), Epstein-Barr virus (Epstein-Barrvirus), hepatitis C virus (HCV), Hantaan virus (Hantaan virus), small corn virus. Many viruses have polyadenylic acid tails (Poly Atail) in RNA replication. Cordycepin is 3′-deoxyadenosine. Due to the lack of hydroxyl at the 3′ position, it can interfere with the formation of RNA polyadenylic acid tails and resist the replication and reproduction of RNA viruses. Therefore, it is defined as an RNA synthesis inhibitor. The coronavirus COVID-19 is a positive-stranded single-stranded RNA virus with an envelope (the same as the polio virus). Experiments have shown that cordycepin has an inhibitory effect on the reproduction of polio virus, a type of positive-stranded single-stranded RNA virus.
[0097] 5. Adenosine receptors and Cordyceps militaris cordycepin enhance the human immune system.
[0098] 6. Increased adenosine is an important natural mechanism for the human immune system to relieve lung inflammation (increased adenosine is an important natural mechanism for the human immune system to relieve lung inflammation, and Cordyceps sinensis cordycepin enhances the immune cell function of lymphocytes and monocytes and macrophages).
[0099] 7. The role of adenosine receptors and cordycepin in acute lung injury (activation of adenosine receptors A2A and A2B protects against acute lung injury, activation of adenosine receptor A3 can resist cytokine storm, cordyceps and cordycepin improve respiratory inflammation as adenosine receptor agonists) Adenosine receptors and cordycepin protect important organs such as the lungs, brain, heart, and kidneys in hypoxemia (in hypoxemia or bacteremia, elevated adenosine activates adenosine receptors to protect the functions of multiple organs, cordyceps and cordycepin protect the lungs, liver, brain, and kidneys in hypoxemia or inflammatory conditions.
[0100] We can produce Cordyceps militaris powder with high cordycepin content, up to 0.5%-3%. Without purification, it can be made into tablets or powders with strong effects (more than 10 mg per tablet). In this way, the cordycepin in the original ecological Cordyceps militaris powder comes with the ADA enzyme inhibitor pentostatin, and is also protected by the original polysaccharide macromolecules, which is very stable and easily absorbed and utilized by the human body. Therefore, Cordyceps militaris with high cordycepin (>1%) can be used as an activator of adenosine receptors A1, A2A, A2B, and A3. It is safe and reliable, and comes with the protective agent pentostatin. It is relatively concentrated and can be made into tablets or granules. It can play its due role in the prevention, auxiliary treatment and rehabilitation of viral pneumonia. Cordycepin plays a role in preventing the generation of cytokine storms and protecting alveolar tissue in coronavirus pneumonia.
[0101] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. An antiviral aerosol liquid, characterized in that: It is made from the following raw materials: water, Cordyceps militaris powder, honeysuckle, edible flavors, edible glycerin, natural menthol, ginger powder and licorice powder.
2. The antiviral atomized liquid according to claim 1, characterized in that: The raw materials are calculated by weight percentage: 90-93% of water, 1-3% of cordyceps militaris, 0.3-1.5% of honeysuckle, 0.3-1.5% of edible flavor, 0.3-1.5% of edible glycerin, 0.3-1.5% of natural menthol, 0.3-1.5% of ginger powder and 0.3-1.5% of liquorice powder.
3. The antiviral atomized liquid according to claim 1, characterized in that: The raw materials are calculated by weight percentage: 91% water, 3% cordyceps militaris, 1% honeysuckle, 1% edible flavor, 1% edible glycerin, 1% natural menthol, 1% ginger powder, and 1% licorice powder.
4. A process for preparing an antiviral atomized liquid, characterized in that: The steps include: Step 1, selecting raw materials, selecting raw materials in the weight percentages described in claim 3; Step 2, extracting cordycepin, enzymolyzing Cordyceps militaris to obtain a crude extract, uniformly mixing the crude extract with 80-90% by volume of an ethanol aqueous solution as an entrainer, wherein the mass ratio of the crude extract to the entrainer is 1:10; after balancing for 10-30 minutes, performing dynamic extraction to obtain a cordycepin mixture; Step 3, adding a diluent, adding edible glycerin to the cordycepin mixture; Step 4, seasoning and sweetening, adding honeysuckle liquid, edible flavor, natural menthol, ginger powder and licorice powder to the cordycepin mixture; Step 5: Filtration and purification: filtering the atomized liquid to remove impurities and sediments; Step 6: Aging: The atomized liquid is aged for a period of time to allow the flavors to blend and mature; Step 7: Testing: performing HPLC analysis, GC-MS testing and toxicity screening on the atomized liquid; Step 8: Packaging and storage.
Citation Information
Patent Citations
Atomized liquid containing cordyceps militaris extract and application thereof
CN114028435A
Cordycepin mixture as well as effective separation method and application thereof
CN114042092A
Atomized liquid containing cordyceps militaris extract and rosemary extract and application thereof
CN114129616A
Atomized liquid for preventing and treating influenza as well as preparation method and administration method thereof
CN114533707A
